<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03727503</url>
  </required_header>
  <id_info>
    <org_study_id>P2018/487</org_study_id>
    <nct_id>NCT03727503</nct_id>
  </id_info>
  <brief_title>Casptesia Versus PICCO in Cardiac Surgical Patients in the ICU</brief_title>
  <acronym>Capstesia</acronym>
  <official_title>Ability of a New PPV Smartphone Application to Predict Fluid Responsiveness in Cardiac Surgical Patients in the ICU</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Erasme University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Erasme University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to assess the ability of a new smartphone PPV app to predict fluid
      responsiveness in cardiac surgical patients in the Intensive care unit (in the postoperative
      period)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pulse pressure variation (PPV) remains a good predictor of fluid responsiveness in the ICU in
      ventilated and sedated patients. However, PPV can be time-consuming to calculate (manual
      determination), is not always displayed on monitoring screens nor reliable through visual
      assessment and needs additional often costly devices to be displayed. A new Android
      application (Captesia) automatically calculates the PPV utilizing a digital photograph of the
      arterial waveform from the monitor. The application determines the PPV by selecting peaks and
      troughs of the arterial curve.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Logisitic problem
  </why_stopped>
  <start_date type="Actual">March 27, 2019</start_date>
  <completion_date type="Actual">January 1, 2020</completion_date>
  <primary_completion_date type="Actual">January 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Agreement and precision between two methods to measure pulse pressure variation (PPV)</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>PPV measure</measure>
    <time_frame>baseline</time_frame>
    <description>PPV before with after 2 maneuvers which modify PPV (increase PEEP level and mini-fluid challenge)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>PPV measure</measure>
    <time_frame>1 minute after the end of volume expansion</time_frame>
    <description>PPV before with after 2 maneuvers which modify PPV (increase PEEP level and mini-fluid challenge)</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Surgery</condition>
  <arm_group>
    <arm_group_label>group/cohort</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>operated patients from cardiac surgery. Once they arrived in the ICU, we will measure PPV with the capstesia and the PICCO device at baseline, and after a volume expansion of 500 ml of crystalloid.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>PPV from the capstesia</intervention_name>
    <description>we will challenge the application by doing 2 maneuvers: the first one is to increase the PEEP level from 5 to 15 cmH2O and the second one is the infusion of a mini-fluid challenge (100 ml) followed by the other 400 ml.</description>
    <arm_group_label>group/cohort</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adults patients ( &gt;18 years)

          -  Patients scheduled for cardiac surgery

          -  equipped with a femoral arterial catheter and the PICCO device

        Exclusion Criteria:

          -  Atrial fibrillation

          -  severe cardiac dysfunction
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexandre Joosten, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>ERASME</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Erasme Hospital</name>
      <address>
        <city>Brussels</city>
        <zip>1070</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>October 29, 2018</study_first_submitted>
  <study_first_submitted_qc>October 31, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 1, 2018</study_first_posted>
  <last_update_submitted>January 27, 2020</last_update_submitted>
  <last_update_submitted_qc>January 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Erasme University Hospital</investigator_affiliation>
    <investigator_full_name>Alexandre Joosten, MD PhD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

